News
Future Diagnostics Enters Agreement with DIAsource Immunoassays for Free 25OH Vitamin D ELISA product
DIAsource Immunoassays (Louvain-la-Neuve, Belgium), a BioVendor group company, has entered into a strategic agreement with Future Diagnostics (Wijchen, The Netherlands) under which Future Diagnostics will transfer all assets, with the exclusion of IP, related to Free 25OH Vitamin D ELISA product to DIAsource, securing its continued production and sales.
Top 10 IVD Solution Provider in Europe – 2020
We are very proud that Future Diagnostics Solutions is recognized by MedTech Outlook Magazine as TOP 10 In Vitro Diagnostic Solution Provider in Europe – 2020.
PhD promotion Giuliana Ascone – Euroclast
Future Diagnostics is proudly announcing the PhD promotion of Giuliana Ascone. Giuliana was ESR in the Marie Curie Euroclast project supported by Future Diagnostics and working at the Department of Experimental Rheumatology of the Radboud University.
Successful FDA inspection at Future Diagnostics
Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.
TTW funded Biomonitor project
Sensing technologies for acquiring real-time, precise, and reliable data are becoming more and more important in the field of healthcare, to help monitor, treat and coach patients. Future Diagnostics Solutions is proud to be a partner in the TTW funded Biomonitor project aiming at the development of continuous monitoring sensors.
BIOCDx EU Project
Future Diagnostics is proud to be part of the BIOCDx EU Project: A miniature Bio-photonics Companion Diagnostics platform for reliable cancer diagnosis and treatment monitoring.